Javascript must be enabled to continue!
Abstract A010 The role of TP53 on transposable elements in pediatric cancer
View through CrossRef
Abstract
Background: Transposable elements (TEs) are dynamic repetitive regions which generate mutations and structural variants. TP53 plays a crucial role in suppressing TE movement to maintain genomic stability. The relationship between TP53 and TEs has been extensively studied in tumours, but not the germline. Individuals with germline TP53 pathogenic variants have Li-Fraumeni Syndrome (LFS), a cancer predisposition syndrome with a high lifetime risk of cancer in various tissues. This study aims to characterize the TE landscape in individuals with Li-Fraumeni Syndrome and determine how this contributes to their increased cancer risk. Methods: MELT and xTea were used to identify TEs in children with (n=48) or without (n=198) a germline TP53 variant. TE calls were merged with SURVIVOR and variants were annotated with AnnotSV. To assess the influence of TP53 on TE location, we quantified TEs across genomic windows and identified the top 100 significantly different regions with the Mann-Whitney U test, adjusting for multiple comparisons. We used these regions to develop a gradient-boosted tree model with 5-fold cross-validation to predict TP53 status. Results: Individuals with germline TP53 variants harboured significantly fewer ALU and LINE1 elements in their germline genome compared to the control dataset (p<0.001). The phenomenon was consistent across chromosomes and significant in chromosomes 5 and 11 (FDR<0.05). A gradient-boosted tree model was able to differentiate patients with and without a germline TP53 variant with an AUPRC of 0.77 on an unseen test set. Conclusion: Germline TP53 variants may effect the frequency and location of germline TE insertions, which may influence nearby genomic variations and lead to cancer development. Analyzing TEs in individuals with LFS will enhance our understanding of accelerated cancer development in these patients, informing future research for diagnostic and therapeutic approaches.
Citation Format: Brianne Laverty, Shilpa Yadahalli, Vallijah Subasri, David Malkin. The role of TP53 on transposable elements in pediatric cancer [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pediatric Cancer Research; 2024 Sep 5-8; Toronto, Ontario, Canada. Philadelphia (PA): AACR; Cancer Res 2024;84(17 Suppl):Abstract nr A010.
American Association for Cancer Research (AACR)
Title: Abstract A010 The role of TP53 on transposable elements in pediatric cancer
Description:
Abstract
Background: Transposable elements (TEs) are dynamic repetitive regions which generate mutations and structural variants.
TP53 plays a crucial role in suppressing TE movement to maintain genomic stability.
The relationship between TP53 and TEs has been extensively studied in tumours, but not the germline.
Individuals with germline TP53 pathogenic variants have Li-Fraumeni Syndrome (LFS), a cancer predisposition syndrome with a high lifetime risk of cancer in various tissues.
This study aims to characterize the TE landscape in individuals with Li-Fraumeni Syndrome and determine how this contributes to their increased cancer risk.
Methods: MELT and xTea were used to identify TEs in children with (n=48) or without (n=198) a germline TP53 variant.
TE calls were merged with SURVIVOR and variants were annotated with AnnotSV.
To assess the influence of TP53 on TE location, we quantified TEs across genomic windows and identified the top 100 significantly different regions with the Mann-Whitney U test, adjusting for multiple comparisons.
We used these regions to develop a gradient-boosted tree model with 5-fold cross-validation to predict TP53 status.
Results: Individuals with germline TP53 variants harboured significantly fewer ALU and LINE1 elements in their germline genome compared to the control dataset (p<0.
001).
The phenomenon was consistent across chromosomes and significant in chromosomes 5 and 11 (FDR<0.
05).
A gradient-boosted tree model was able to differentiate patients with and without a germline TP53 variant with an AUPRC of 0.
77 on an unseen test set.
Conclusion: Germline TP53 variants may effect the frequency and location of germline TE insertions, which may influence nearby genomic variations and lead to cancer development.
Analyzing TEs in individuals with LFS will enhance our understanding of accelerated cancer development in these patients, informing future research for diagnostic and therapeutic approaches.
Citation Format: Brianne Laverty, Shilpa Yadahalli, Vallijah Subasri, David Malkin.
The role of TP53 on transposable elements in pediatric cancer [abstract].
In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pediatric Cancer Research; 2024 Sep 5-8; Toronto, Ontario, Canada.
Philadelphia (PA): AACR; Cancer Res 2024;84(17 Suppl):Abstract nr A010.
Related Results
Targeting Mutant p53 in Pediatric Acute Lymphoblastic Leukemia
Targeting Mutant p53 in Pediatric Acute Lymphoblastic Leukemia
Abstract
Mutations of the tumor suppressor gene TP53 have been described to be associated with aggressive disease and inferior prognosis in different types of cancer...
Characterization of Hematopoiesis in Tp53 R172H Mutant Mice
Characterization of Hematopoiesis in Tp53 R172H Mutant Mice
Abstract
In a cohort of 150 patients with myelodysplastic syndrome (MDS), the most common adult myeloid malignancy, missense mutations in TP53 were more common than ...
Response To Azacitidine Is Independent Of TP53 Mutations In Higher-Risk Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)
Response To Azacitidine Is Independent Of TP53 Mutations In Higher-Risk Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)
Abstract
Introduction
Higher-risk myelodysplastic syndromes (MDS) progress to secondary acute myeloid leukemia (sAML) within mon...
High Resolution Melt Analysis for Rapid and Cost-Effective Screening of TP53 Mutations in Patients with Myeloid Malignancies
High Resolution Melt Analysis for Rapid and Cost-Effective Screening of TP53 Mutations in Patients with Myeloid Malignancies
Abstract
Background
Recent reports have highlighted an adverse impact of TP53 mutations on the prognosis of patients with myeloid malignancies. TP53 m...
Comparison of TP53 Alterations in Hematological Malignancies
Comparison of TP53 Alterations in Hematological Malignancies
Abstract
Background: TP53 is altered in ~50% of human cancers. Alterations include mutations and deletions. Both frequently occur together, supportin...
Abstract 4442: TP53 hot spot mutations in ovarian cancer: Selective resistance to microtubule stabilizing agents in monoclonal cells and comparison of clinical outcomes from The Cancer Genome Atlas data
Abstract 4442: TP53 hot spot mutations in ovarian cancer: Selective resistance to microtubule stabilizing agents in monoclonal cells and comparison of clinical outcomes from The Cancer Genome Atlas data
Abstract
TP53 is mutated in 96% of high grade serous epithelial ovarian carcinomas (HGS EOC) sequenced by The Cancer Genome Atlas (TCGA). Missense mutations at hot s...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
A06 | TP53 in myeloid neoplasms
A06 | TP53 in myeloid neoplasms
The TP53 gene encodes the transcription factor p53, a central regulator of genomic integrity and stem-cell fitness. Loss of TP53 function, through genetic mutations and/or deletion...

